Synthesis and antifunsal evaluation of 6-(N-arylamino)-7-metnylthio-5,8-quinolinediones

Archives of Pharmacal Research

Volumn 21, Issue 4, 1998, Pages 440-444

  Ryu, Chung Kyu ^a   Choi, Jung Ah ^a   Kim, Sung Hee ^a  

^a Ewha Womans University   (South Korea)

Author keywords

6 (N Arylamino) 7 methylthio 5,8 quinolinedione; Antifungal activity; Candida species; MIC minimum inhibitory concentration

Indexed keywords

6 (N (4 BROMO 2 METHYLPHENYL)AMIMO) 7 METHYLTHIO 5,8 QUINOLINEDIONE; 6 (N (4 BROMO 3 METHYLPHENYL)AMINO) 7 METHYLTHIO 5,8 QUINOLINEDIONE; 6-(N-(4-BROMO-2-METHYLPHENYL)AMIMO)-7-METHYLTHIO-5,8-QUINOLINEDIONE; 6-(N-(4-BROMO-3-METHYLPHENYL)AMINO)-7-METHYLTHIO-5,8-QUINOLINEDIONE; AMINOQUINOLINE DERIVATIVE; ANTIFUNGAL AGENT; QUINOLONE DERIVATIVE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CHEMISTRY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; SYNTHESIS;

AMINOQUINOLINES; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0032129964     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974640     Document Type: Review

References (12)

1. Bowman, C. M., Porter, T. H., Skelton, F. S. and Folkers, K., 5,8-Quinolinequinone analogs which inhibit mitochondrial succinoxidase. J. Med. Chem., 16, 206-209 (1973).
2. Georgopapadakou, N. H. and Walsh. J., Human mycoses: Drugs and targets for emerging pathogens. Science, 264, 371-373 (1994).
3. Hudson, A. T., Atovaquone-A novel agent for the treatment of malaria, PCP and toxoplasmosis. In Bentley, P. H. and Ponsford, R. (Eds.). Recent Advances in the Chemistry of Anti-infective Agents. Royal Society of Chemistry, Cambridge, pp. 322-335, 1992.
4. Jeschke, P., Linder, W., Mueller, N. and Dehne, H. W., Fungicides based on amino-substituted quinolinequinones. Ger. Offen., DE 4,208,874 (1993).
5. Mcginnis M. R. and Rindali, M. G., Antifungal drug. In Lorian, V. (Eds.), Antibiotics in Laboratory Medicine (4th ed). Williams and Wilkins, Baltimore, pp. 176-211, 1996.
6. Pratt, Y. T. and Drake, N. L., Synthesis of 6,7-dichloroquinoline-5,8-quinone. J. Am. Chem. Soc., 82, 1155-1160 (1960).
7. Roberts, H., Choo, W. M., Smith, S. C., Marzuki, S., Linnane, A. W., Porter, T. H. and Folkers, K., The site of inhibition of mitochondrial electron transfer by coenzyme Q analogs. Arch. Biochem. Biophys., 191, 306-315 (1978).
8. Ryu, C. K., Kim, D. H. Kwon, S. M., Jung, S. H. and Kim, S. H., In vitro and in vivo antifungal activities of 6-[(N-4-bromophenyl)amino]-7-chloro-5,8-quinolinediones. Arch. Pharm. Res., 20, 586-589 (1997).
9. Ryu, C. K. and Kim, D. H., The antifungal susceptibility tests of 5,8-quinolinediones against Candida species. Arch. Pharm. Res., 17, 483-486 (1994a).
10. Ryu, C. K. and Kim, H. J., The synthesis of 6-(N-arylamino)-7-chloro-5,8-quinolinedione derivatives for evaluation of antifungal activities. Arch. Pharm. Res., 17, 139-144 (1994b).
11. Schellhammer, C. W. and Petersen, S., Ueber Derivatives des 5,8-Chinolinchinone. Ann. der Chem., 624, 108-119 (1959).
12. Sternberg, S., The emerging fungal threat. Science, 266, 1632-1634 (1994).